Ignite Creation Date:
2025-12-26 @ 11:00 AM
Ignite Modification Date:
2025-12-29 @ 5:37 PM
Study NCT ID:
NCT05018806
Status:
COMPLETED
Last Update Posted:
2024-06-21
First Post:
2021-08-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-23
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-19
First Submit QC Date:
None
Study First Post Date:
2021-08-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-06-21
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2024-06-20
Last Update Post Date:
2024-06-21
Last Update Post Date Type:
ACTUAL